NDC 63561-0165-01 - Furosemide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63561-0165
- Requested NDC
- 63561-0165-01
- Package NDCs from labels
- 63561-0165-9, 63561-0165-2, 63561-0165-1, 63561-0165-01
- Manufacturer
- Granulation Technology, Inc.
- Effective date
- 2026-06-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Furosemide Tablets, USP | Granulation Technology, Inc. | 2026-06-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63561-0165-1 | Furosemide | 100 in 1 BOTTLE | TABLET | 100 | 2 | |
| 63561-0165-2 | Furosemide | 1000 in 1 BOTTLE | TABLET | 1000 | 2 | |
| 63561-0165-9 | Furosemide | 90 in 1 BOTTLE | TABLET | 90 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63561-0165-1 | EA - Each | 63561-0165 | 5b4a080e-0ce1-4174-82bd-7f219f91ebe6 | 1 | 2026-03-17 |
| 63561-0165-2 | EA - Each | 63561-0165 | 5bfd08b2-98cd-4997-88c8-b22807717507 | 1 | 2026-03-17 |
| 63561-0165-9 | EA - Each | 63561-0165 | da688462-fc82-4b6a-9ea2-4d9e2ca393f6 | 1 | 2026-03-17 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FUROSCIX | FUROSEMIDE INJECTION 80 MG/ 10 ML | scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation | eac958dd-8d43-e44e-e053-2995a90a4d5e | 2026-07-31 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | 7cdcd001-ab4b-4210-a455-2e17a7bc4972 | 2026-07-24 | Warnings, Adverse reactions | 310429 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | 3d312ab0-589c-427b-84da-18887244bfc9 | 2026-07-15 | Warnings, Adverse reactions | 310429 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | St. Mary's Medical Park Pharmacy | febeaf8c-0f4b-cc40-e053-6394a90a873e | 2026-06-30 | Warnings, Adverse reactions | 313988 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | 916de29e-228c-4dfc-bcee-ad9a641316bd | 2026-06-24 | Warnings, Adverse reactions | 313988 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | e8c27f1c-dc81-44b1-8663-a7d663bad89f | 2026-06-23 | Warnings, Adverse reactions | 310429 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | 571a52ed-5258-46d5-a0d2-9a984cf73895 | 2026-06-23 | Warnings, Adverse reactions | 310429 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Atlantic Biologicals Corp. | 54ed0dd9-2fa8-269a-e063-6294a90a607c | 2026-06-23 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | 75d5611a-f9e0-1841-e053-2991aa0af415 | 2026-06-23 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Unit Dose Solutions, Inc. | 54dd664a-c7ec-27f3-e063-6294a90aff9f | 2026-06-22 | Warnings, Adverse reactions | 310429 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | 2a5bcf50-6d63-463a-915e-a72ea2e5f131 | 2026-06-18 | Warnings, Adverse reactions | 313988 310429 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Granulation Technology, Inc. | 462e8917-cbe0-f4f9-e063-6394a90ab4ff | 2026-06-17 | Warnings, Adverse reactions | NDA018569 63561-0164-9 63561-0165-9 63561-0166-1 63561-0164-1 63561-0166-5 63561-0165-2 63561-0164-2 63561-0166-9 63561-0165-1 63561-0164 63561-0165 63561-0166 63561016501 313988 197732 310429 54741cba-d4ee-617e-e063-6294a90ad1eb 462e8917-cbe0-f4f9-e063-6394a90ab4ff 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Atlantic Biologicals Corps | 9c342198-7162-4cc5-bda1-bc4054a4292b | 2026-06-16 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Coupler LLC | 53e58232-f7f9-c09b-e063-6394a90a5bc4 | 2026-06-10 | Warnings, Adverse reactions | 310429 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | 42478c55-9056-487a-89a9-d36904beea12 | 2026-06-02 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Major Pharmaceuticals | 6be1addd-a811-47fc-8650-6870d661c234 | 2026-05-26 | Warnings, Adverse reactions | 313988 310429 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | 71b48f4d-9936-448c-9e3a-33f1182e1039 | 2026-05-15 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Hospira, Inc. | 39fd32f2-6bb7-4a65-d298-e48d26bc80c7 | 2026-05-13 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | Hospira, Inc. | aaced7a8-c3d7-4d66-8c07-aa407b8b3f35 | 2026-05-13 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | 8e0bac29-5a8b-4d4e-93b3-2e21eb3b0650 | 2026-05-06 | Warnings, Adverse reactions | 7LXU5N7ZO5 |